The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Administration of F1 Modular and General Update

30 Mar 2020 13:59

RNS Number : 0842I
Ashley House PLC
30 March 2020
 

 

 

 

 

30 March 2020

 

 

Ashley House plc

Administration of F1 Modular and General Update

 

Ashley House plc ("Ashley House" or the "Company") the health and housing property partner today provides the market with a further update.

F1 Modular Limited

On 6 March, the Company advised that F1 Modular Limited ("F1M") the Company's 76% subsidiary had filed a Notice of the Intention to Appoint an Administrator. The Company now advises that F1M, having carefully considered its financial position, has appointed two partners from RSM Restructuring Advisory LLP ("RSM") as Administrator. RSM is continuing to pursue an accelerated sale process to find a buyer for the business. Should a sale process not be completed the F1M business would be shut down.

Trading Update

As advised in the Update dated 6 March, the Company continues to urgently pursue legal remedies to recover long overdue receivables in excess of £1m. The Board is pleased that agreement has been reached with one of these parties, with the corresponding payment expected in the near future.

As advised in same Update, the Company continues to seek the funding required both to meet its ongoing working capital commitments and to support its affordable housing strategy. Discussions continue with potential equity investors, although difficulties and uncertainty caused by the Covid-19 pandemic is inevitably causing delay both to the potential equity raise and to trading in general. Accordingly, the Company is also seeking support from its bankers under the Coronavirus Business Interruption Loan Scheme. If ultimately unsuccessful or not achieved in timely fashion and in the absence of other sources of funding, the Company will not be able to continue to trade.

Board Composition

In light of the above, the Company continues to implement cost cutting measures wherever possible. As part of this, two of the Non-executive directors, Christopher Lyons (Chairman) and Andrew Willetts, whilst remaining supportive of the Company, have agreed to step down from the Board with immediate effect. Until such time as trading in its shares resumes, Ashley House will operate with the three existing Executive directors and one Non-executive director, Adrian Wright, to ensure appropriate governance. The remaining Directors thank Christopher and Andrew for all their efforts in the last years.

Share Trading

Ashley House's shares on AIM remain suspended pending further clarification. The Company confirms that trading in Ashley House shares on NEX was withdrawn from 26 March.

 

Year End Accounts

On 14 November 2019, the Company advised that the report and accounts for the 18 month period from 1 May 2018 to 31 October 2019 would be released by the end of March 2020. In line with other companies in the wake of the Covid-19 crisis, Ashley House has requested from Companies House a three month extension such that the report and accounts will be filed by 31 July 2020.

 

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

Ashley House plc 01628 600 340

Antony Walters

Jonathan Holmes

James Hathaway

 

WH Ireland 0207 220 1666

(Nominated Adviser and Broker)

Adrian Hadden

James Sinclair-Ford

Darshan Patel

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSDLFESESSEID
Date   Source Headline
29th Jun 20189:08 amRNSDirectorate change
10th May 20187:00 amRNSHolding(s) in Company
9th May 20182:05 pmRNSSecond Price Monitoring Extn
9th May 20182:00 pmRNSPrice Monitoring Extension
9th May 20187:00 amRNSTrading Update
3rd May 20185:38 pmRNSDirector/PDMR Shareholding
6th Mar 20183:00 pmRNSDirector Dealing
5th Mar 20187:00 amRNSFinancial Close Scarborough Extra Care
1st Mar 20187:00 amRNSAppointment of Finance Director
23rd Feb 201811:54 amRNSHolding(s) in Company
14th Feb 20188:51 amRNSSale of Pharmacy Interest to Repay Debt - Amended
14th Feb 20187:00 amRNSSale of Pharmacy Interest to Repay Debt
2nd Feb 20189:32 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSInterim Results
30th Jan 20184:31 pmRNSDirectors' & PDMRs' Dealings
22nd Dec 20171:07 pmRNSDirector/PDMR Shareholding
15th Dec 20171:56 pmRNSJoint Venture with Morgan Sindall Investments Ltd
24th Nov 20177:00 amRNSUpdate
7th Nov 201711:00 amRNSHolding(s) in Company
31st Oct 20172:28 pmRNSDirectors' & PDMRs' Dealings
26th Oct 20177:00 amRNSUpdate
25th Oct 201712:35 pmRNSResult of AGM
3rd Oct 201710:45 amRNSHolding(s) in Company
3rd Oct 20179:25 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreliminary Results For The Year End 30 April 2017
28th Jul 20174:45 pmRNSDirectors' & PDMRs' Dealings
4th Jul 20174:27 pmRNSDebt Facility from Related Party
28th Apr 20172:20 pmRNSDirectors' & PDMRs' dealings
25th Apr 20173:16 pmRNSDebt Facility from Related Party
27th Mar 201711:09 amRNSDirector Dealing
17th Mar 20173:42 pmRNSDirector Dealing
14th Mar 20171:11 pmRNSAcquisition and Trading Update
22nd Feb 201712:03 pmRNSPosting of Interim Report
30th Jan 20171:27 pmRNSDirectors' & PDMRs' dealings
26th Jan 20177:00 amRNSInterim Report 2016
17th Jan 201710:27 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSReplacement Debt Facility from Related Party
28th Oct 20168:41 amRNSDirectors' & PDMRs' dealings
15th Sep 201610:48 amRNSResult of AGM
23rd Aug 20167:00 amRNSReport and Accounts / AGM
28th Jul 20167:00 amRNSDirectors' & PDMRs' Dealings
13th Jul 201611:58 amRNSDirector/PDMR Shareholding
13th Jul 20167:00 amRNSPreliminary results
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 201610:22 amRNSDirectors' & PDMRs' dealings
29th Mar 20167:00 amRNSDirectors & PDMRs dealings
1st Mar 201611:09 amRNSDirector Dealing
10th Feb 20167:00 amRNSAdmission Application Announcement
5th Feb 20165:27 pmRNSPosting of Interim Report
26th Jan 20167:00 amRNSInterim Report 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.